About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Psoriasis Clinical Trials in Houston | 184 Studies | Clareo Health

Clinical Trials PsoriasisHouston

Psoriasis Clinical Trials in Houston

Find 184 clinical trials for psoriasis near Houston, Texas. Connect with research centers in your area.

All Psoriasis trials nationwide All trials in Houston

Filters

Sort by

Status

Recruiting(Enrolling)

Not yet recruiting

Active, not recruiting

Enrolling by invitation(Enrolling)

Completed

Terminated

Phase

Early Phase 1

Phase 1

Phase 1/Phase 2

Phase 2

Phase 2/Phase 3

Phase 3

Phase 4

Not Applicable

Eligibility

Accepts healthy volunteers

Showing 181-184 of 184 trials

COMPLETEDPhase 3< 1 mile

A Study to Assess the Long-Term Safety of Tacrolimus Cream in the Treatment of Psoriasis

NCT00293917

A study to assess the long-term safety of tacrolimus cream in the treatment of psoriasis

Astellas Pharma Inc658 participantsStarted Jan 2006

Birmingham, Alabama, United States • Fresno, California, United States • Santa Monica, California, United States +34 more locations

COMPLETEDPhase 347 miles

A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of Psoriasis

NCT00293930

A study to assess the safety and effectiveness of tacrolimus cream in the treatment of psoriasis

Astellas Pharma Inc645 participants

Hot Springs, Arkansas, United States • San Diego, California, United States • San Francisco, California, United States +29 more locations

Psoriasis Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

COMPLETEDPhase 1/2146 miles

Study of Intra-articular Delivery of tgAAC94 in Inflammatory Arthritis Subjects

NCT00126724

The 13G01 clinical trial is a Phase I/II dose escalation study designed to be conducted in adults with inflammatory arthritis who have persistent moderate or severe swelling in one or more joints, without a disease severe enough to warrant a change in regimen for the next three months. The study will permit subjects who are concurrently on anti-tumor necrosis factor (TNF)-alpha antagonists. For subjects on disease modifying antirheumatic drugs (DMARDs), a stable regimen for inflammatory arthritis for the previous three months, with no changes in doses in the four weeks prior to screening will be required. The primary objectives are: 1. to evaluate the safety of intra-articular administration of tgAAC94 in subjects currently taking TNF-alpha antagonists, and 2. to evaluate the safety of repeat intra-articular administration of tgAAC94 (gene therapy vector).

Arthritis, RheumatoidArthritis, PsoriaticAnkylosing Spondylitis

Targeted Genetics Corporation120 participantsStarted Aug 2005

Glendale, Arizona, United States • Tuscon, Arizona, United States • Palm Desert, California, United States +19 more locations

TERMINATEDPhase 2225 miles

Study of BMS-587101 in Patients With Moderate to Severe Psoriasis

NCT00162253

The purpose of this clinical research study is to learn if BMS-587101 is effective on the treatment of Moderate to Severe Psoriasis. The safety of this treatment will also be studied.

Psoriasis, Moderate to Severe

Bristol-Myers Squibb120 participantsStarted Apr 2005

Phoenix, Arizona, United States • Tucson, Arizona, United States • San Diego, California, United States +13 more locations

PreviousPage 10 of 10

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia